Tag: donanemab fda approval
FDA Approves Eli Lilly Alzheimer’s Drug Kisunla Amid Safety Concerns
The path to the FDA's July 15 approval of donanemab was paved with controversy, clinical risk, and a desperate need for answers. Alzheimer's disease afflicts mi
